Last updated: 23 February 2021 at 4:54pm EST

Mark Elvig Net Worth




The estimated Net Worth of Mark F Elvig is at least $886 Thousand dollars as of 31 December 2020. Mark Elvig owns over 2,600 units of Core Laboratories Inc stock worth over $225,250 and over the last 16 years he sold CLB stock worth over $660,895. In addition, he makes $0 as General Counsel and Secretary at Core Laboratories Inc.

Mark Elvig CLB stock SEC Form 4 insiders trading

Mark has made over 42 trades of the Core Laboratories Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 2,600 units of CLB stock worth $42,952 on 31 December 2020.

The largest trade he's ever made was exercising 4,800 units of Core Laboratories Inc stock on 31 December 2012 worth over $79,296. On average, Mark trades about 775 units every 69 days since 2008. As of 31 December 2020 he still owns at least 13,635 units of Core Laboratories Inc stock.

You can see the complete history of Mark Elvig stock trades at the bottom of the page.





Mark Elvig biography

Mark Elvig is the General Counsel, Secretary at Core Laboratories Inc.



What's Mark Elvig's mailing address?

Mark's mailing address filed with the SEC is 6316, Windfern Road, Houston, Harris County, Texas, 77040, United States.

Insiders trading at Core Laboratories Inc

Over the last 24 years, insiders at Core Laboratories Inc have traded over $193,912,801 worth of Core Laboratories Inc stock and bought 26,580 units worth $2,019,042 . The most active insiders traders include Sachs Group Incgoldman Sach..., David M Demshur, and Richard L Bergmark. On average, Core Laboratories Inc executives and independent directors trade stock every 20 days with the average trade being worth of $220,063. The most recent stock trade was executed by Mark Damian Tattoli on 1 August 2024, trading 370 units of CLB stock currently worth $6,112.



What does Core Laboratories Inc do?

core laboratories is a leading provider of proprietary and patented reservoir description and production enhancement services. core laboratories remains dedicated to providing the technology you need to enhance your production. we continue to develop and acquire technologies that complement our existing products and services, and we disseminate these technologies throughout our global network. with over 70 offices in more than 50 countries located in major oil-producing provinces, core laboratories provides services to the world's major, national, and independent oil companies. we can help you solve your reservoir problems. core laboratories'​ reservoir optimization technologies are used to increase total recovery from existing fields. our services enable our clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. core laboratories has taken extensive measures to ensure the services and data provided by all of our worldwide companies are



Complete history of Mark Elvig stock trades at Core Laboratories Inc

Insider
Trans.
Transaction
Total value
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $68,926
31 Dec 2020
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $90,408
31 Dec 2019
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $178,980
31 Dec 2018
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $328,650
29 Dec 2017
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $264,088
30 Dec 2016
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $326,220
31 Dec 2015
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $326,220
31 Dec 2015
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $114,040
30 Jun 2015
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $361,020
31 Dec 2014
Mark F Elvig
SVP, Gen Counsel, and Secretary
Sale $138,030
17 Nov 2014
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $167,060
30 Jun 2014
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $141,603
1 Apr 2014
Mark F Elvig
SVP, Gen Counsel, and Secretary
Sale $279,960
14 Feb 2014
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $668,325
31 Dec 2013
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $151,660
30 Jun 2013
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $14,258
22 Apr 2013
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $93,884
1 Apr 2013
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $27,276
1 Mar 2013
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $524,688
31 Dec 2012
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $41,272
1 Dec 2012
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $115,900
30 Jun 2012
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $92,099
1 Apr 2012
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $24,820
1 Mar 2012
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $46,908
1 Dec 2011
Mark F Elvig
SVP, Gen Counsel, and Secretary
Sale $242,905
25 Jul 2011
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $111,540
30 Jun 2011
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $72,597
1 Apr 2011
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $20,058
1 Mar 2011
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $34,724
1 Dec 2010
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $36,900
30 Jun 2010
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $23,296
1 Apr 2010
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $6,218
1 Mar 2010
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $10,860
1 Dec 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $21,848
27 Oct 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $17,402
22 May 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $12,936
1 Apr 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $49,998
12 Mar 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $2,166
9 Mar 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $3,770
1 Mar 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $39,156
25 Feb 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Buy $83,304
23 Feb 2009
Mark F Elvig
SVP, Gen Counsel, and Secretary
Option $5,820
1 Dec 2008


Core Laboratories Inc executives and stock owners

Core Laboratories Inc executives and other stock owners filed with the SEC include: